DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Zura Bio (NASDAQ:ZURA), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Inozyme Pharma (NASDAQ:INZY).
DBV Technologies has a consensus price target of $6.00.
The stock price for DBV Technologies (NASDAQ: DBVT) is $4.4 last updated February 21, 2025 at 4:08 PM EST.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.